Percheron Therapeutics LimitedASX: PER

Dosing commenced in the ATL1102 toxicology study

Mar 14, 2023 at 2:22 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment